Neuronetics
STIM
82 hedge funds and large institutions have $119M invested in Neuronetics in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 27 increasing their positions, 25 reducing their positions, and 6 closing their positions.
4,588% more call options, than puts
Call options by funds: $750K | Put options by funds: $16K
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
119% more capital invested
Capital invested by funds: $54.4M → $119M (+$64.8M)
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
8% more funds holding
Funds holding: 76 → 82 (+6)
1.08% more ownership
Funds ownership: 63.37% → 64.44% (+1.1%)
8% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$3.38M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$2.07M |
| 3 |
Morgan Stanley
New York
|
+$1.89M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$1.43M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$654K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.21M |
| 2 |
CC
Cannell Capital
Alta,
Wyoming
|
-$1.03M |
| 3 |
Goldman Sachs
New York
|
-$664K |
| 4 |
PFM
Premier Fund Managers
Guildford,
United Kingdom
|
-$566K |
| 5 |
Renaissance Technologies
New York
|
-$364K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
76
Tower Research Capital (TRC)
New York
| $13K | -$1.6K | -340 | -15% |
|
77
Federated Hermes
Pittsburgh,
Pennsylvania
| $4.17K | -$3.47K | -735 | -55% |
|
|
OIA
78
Optimum Investment Advisors
Chicago,
Illinois
| $1.37K | – | – | – |
|
79
Dimensional Fund Advisors
Austin,
Texas
| $1.31K | +$422K | +89,491 | +89% |
|
80
Wells Fargo
San Francisco,
California
| $1.27K | +$28 | +6 | +3% |
|
|
AP
81
Atwood & Palmer
Kansas City,
Missouri
| $687 | – | – | – |
|
82
Citigroup
New York
| $7 | – | – | – |
|
|
NCM
83
Nantahala Capital Management
New Canaan,
Connecticut
| – | -$1.21M | -380,325 | Closed |
|
|
E
84
Ergoteles
New York
| – | -$356K | -111,805 | Closed |
|
|
PHP
85
Parkman Healthcare Partners
Stamford,
Connecticut
| – | -$273K | -85,866 | Closed |
|
86
Franklin Resources
San Mateo,
California
| – | -$268K | -84,226 | Closed |
|
|
QOP
87
Quinn Opportunity Partners
Charlottesville,
Virginia
| – | -$67.2K | -21,144 | Closed |
|
|
BTWM
88
Baker Tilly Wealth Management
Madison,
Wisconsin
| – | -$40K | -12,624 | Closed |
|
STIM Hedge Fund Activity: Q4 2022 in Review
82 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q4 2022, worth a combined $119M — up 119% from $54.4M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new STIM positions and 6 closed out — a net gain of 7 holders — while 27 added to existing stakes and 25 trimmed.
The largest buyer was Kent Lake Capital, adding an estimated $3.38M. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $1.21M sold.
- 82 institutional investors held Neuronetics (STIM) as of Q4 2022, up from 76 in Q3 2022.
- Funds reported $119M of Neuronetics stock for Q4 2022, up 119% quarter-over-quarter.
- 13 funds opened new Neuronetics positions in Q4 2022 and 6 closed out, a net change of +7 holders.
- The largest Neuronetics buyer in Q4 2022 was Kent Lake Capital, an estimated $3.38M added.
- The largest Neuronetics seller in Q4 2022 was Nantahala Capital Management, an estimated $1.21M sold.
Based on aggregated 13F filings for Q4 2022.